StonvexLoading…
StonvexStonvexStonvexCore line items from KOS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 | Annual 2023 2023-12-31 | Q2 2023 2023-06-30 |
|---|---|---|---|---|
Revenue | $870.14M | $422.29M | $1.72B | $671.08M |
Operating Income | $277.09M | $141.97M | $371.74M | $192.81M |
Net Income | $59.77M | $91.69M | $213.52M | $23.34M |
EPS (Diluted) | $0.32 | $0.19 | $0.44 | $0.22 |
Total Assets | $5.39B | $5.35B | $4.94B | $4.81B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $173.81M | $254.32M | $95.34M | $85.73M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 479.82M | 482.10M | 481.07M | 478.90M |